Capstone Asset Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-8,780
Closed -$264K 1645
2016
Q3
$264K Buy
8,780
+140
+2% +$3.85K 0.01% 1397
2016
Q2
$203K Buy
+8,640
New +$189K 0.01% 1503
2014
Q4
Sell
-10,313
Closed -$187K 1655
2014
Q3
$187K Buy
10,313
+140
+1% +$2.8K 0.01% 1577
2014
Q2
$218K Buy
10,173
+1,186
+13% +$25.4K 0.01% 1549
2014
Q1
$203K Sell
8,987
-300
-3% -$7.33K 0.01% 1650
2013
Q4
$227K Buy
+9,287
New +$219K 0.01% 1700

Other funds holding SRDX

Capstone Asset Management's SRDX Position: Q4 2016 in Review

Capstone Asset Management sold out of Surmodics (SRDX) in Q4 2016, closing a stake of 8,780 shares — an estimated $264K sold.

Capstone Asset Management first reported a position in SRDX in Q4 2013 and held it in 6 quarters. The position peaked at $264K in Q3 2016. 116 funds tracked by Wall St. Rank hold SRDX as of Q4 2016.

  • Capstone Asset Management reported no remaining Surmodics position as of Q4 2016 after selling out during the quarter.
  • Capstone Asset Management sold 8,780 Surmodics shares in Q4 2016, an estimated $264K.
  • Capstone Asset Management first reported a position in Surmodics in Q4 2013 and held it in 6 quarters.
  • Capstone Asset Management's Surmodics position peaked at $264K in Q3 2016.
  • 116 funds tracked by Wall St. Rank held Surmodics as of Q4 2016.

Based on Capstone Asset Management's 13F filing for Q4 2016, filed 17 Jan 2017.